Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brett

Showing results (191-200 of 244) with videos related to

Pageof 25
Sort By:
Aesthetic Surgery Journal|June 2, 2020
Deferiprone Stimulates Aged Dermal Fibroblasts via HIF-1α ModulationAndrea Pagani, B Manuela Kirsch, Ursula Hopfner, et al.
BMC Health Services Research|July 5, 2018
Physicians' preferences for bone metastases treatments in France, Germany and the United KingdomYi Qian, Jorge Arellano, Francesca Gatta, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task ForceJohn F P Bridges, A Brett Hauber, Deborah Marshall, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndromeLarry D Lynd, Mehdi Najafzadeh, Lindsey Colley, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1989
Absorption of paroxetine under various dietary conditions and following antacid intakeW H Greb, M A Brett, G Buscher, et al.
The Patient|January 29, 2016
Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid TumorsYi Qian, Jorge Arellano, A Brett Hauber, et al.
Drugs|January 1, 1990
Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humansM A Brett, G Buscher, E Ellrich, et al.
The Prostate|August 19, 2014
Patient preferences for treatments to delay bone metastasesA Brett Hauber, Jorge Arellano, Yi Qian, et al.
Communicable Diseases Intelligence (2018)|December 28, 2020
An evaluation of enhanced surveillance of hospitalised COVID-19 patients to inform the public health response in VictoriaStephanie J Curtis, Zoe Cutcher, Judith A Brett, et al.
Surgical Endoscopy|January 2, 2015
Incorporating patient-preference evidence into regulatory decision makingMartin P Ho, Juan Marcos Gonzalez, Herbert P Lerner, et al.
Pageof 25

Showing results (191-200 of 244) with videos related to

Sort By:
Pageof 25
Aesthetic Surgery Journal|June 2, 2020
Deferiprone Stimulates Aged Dermal Fibroblasts via HIF-1α ModulationAndrea Pagani, B Manuela Kirsch, Ursula Hopfner, et al.
BMC Health Services Research|July 5, 2018
Physicians' preferences for bone metastases treatments in France, Germany and the United KingdomYi Qian, Jorge Arellano, Francesca Gatta, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task ForceJohn F P Bridges, A Brett Hauber, Deborah Marshall, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndromeLarry D Lynd, Mehdi Najafzadeh, Lindsey Colley, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1989
Absorption of paroxetine under various dietary conditions and following antacid intakeW H Greb, M A Brett, G Buscher, et al.
The Patient|January 29, 2016
Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid TumorsYi Qian, Jorge Arellano, A Brett Hauber, et al.
Drugs|January 1, 1990
Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humansM A Brett, G Buscher, E Ellrich, et al.
The Prostate|August 19, 2014
Patient preferences for treatments to delay bone metastasesA Brett Hauber, Jorge Arellano, Yi Qian, et al.
Communicable Diseases Intelligence (2018)|December 28, 2020
An evaluation of enhanced surveillance of hospitalised COVID-19 patients to inform the public health response in VictoriaStephanie J Curtis, Zoe Cutcher, Judith A Brett, et al.
Surgical Endoscopy|January 2, 2015
Incorporating patient-preference evidence into regulatory decision makingMartin P Ho, Juan Marcos Gonzalez, Herbert P Lerner, et al.
Pageof 25